High-Sensitivity C-Reactive Protein (hs-CRP) Reference Range
For cardiovascular risk assessment, hs-CRP should be interpreted using three risk categories: <1.0 mg/L (low risk), 1.0-3.0 mg/L (average risk), and >3.0 mg/L (high risk), with values ≥10 mg/L requiring repeat testing to exclude acute infection or inflammation. 1
Clinical Interpretation Framework
The CDC/AHA consensus guidelines established these cutpoints based on data from 12 population studies involving 19,000 individuals and 22,403 US adults, representing approximate tertiles of the US population 1. This simplified three-tier system was deliberately designed to mirror cholesterol risk stratification for ease of clinical use.
Key Measurement Parameters
- Assay detection range: hs-CRP assays can accurately detect concentrations from 0.3 mg/L to 10 mg/L 1
- Units: Results must be reported in mg/L (not mg/dL) to one decimal place 1
- Specimen requirements: Fasting is generally not required, though may be necessary for turbidimetric/nephelometric assays 1
- Timing: No diurnal variation exists; collection can occur at any time of day 1
Recommended Testing Protocol
Obtain the average of two independent measurements taken at least 2 weeks apart to establish cardiovascular risk, as biological variation can shift an individual's classification by one tertile 1. This approach accounts for the inherent variability in inflammatory markers.
Critical Clinical Caveats
When Values Exceed 10 mg/L
If hs-CRP ≥10 mg/L, this suggests acute inflammation rather than chronic low-grade inflammation associated with atherosclerosis 1. You must:
- Repeat the test after the acute process resolves
- Evaluate for infection, acute injury, or other inflammatory conditions
- Do not use this value for cardiovascular risk stratification
Context-Specific Thresholds
While the 1.0 and 3.0 mg/L cutpoints apply broadly across sex and race 1, some populations show different distributions:
- Japanese populations may have optimal cutoffs at 0.40 mg/L for men and 0.35 mg/L for women for metabolic syndrome screening 2
- Thai adults showed a reference value of 1.8 mg/L (range 0.2-7.9 mg/L) 3
Laboratory Quality Considerations
Be aware that significant inter-assay variability exists despite standardization efforts 1. The College of American Pathologists surveys revealed CVs ranging from 8-14% at 1.0 mg/L and 4-12% at 2.0 mg/L after excluding reporting errors 1. Verify your laboratory reports results in mg/L, not mg/dL—a common source of 10-fold errors 1.
Prognostic Implications
Recent evidence confirms that both the 2 mg/L and 3 mg/L thresholds predict increased cardiovascular events in patients undergoing PCI, with patients having values between 2-3 mg/L showing 44% higher risk of major adverse cardiovascular events compared to those <2 mg/L 4. This supports using the lower 1.0 mg/L threshold to identify truly low-risk individuals.
The hs-CRP value reflects residual inflammatory risk independent of LDL-cholesterol levels 5, 6, making it particularly valuable for identifying patients who may benefit from anti-inflammatory therapies beyond standard lipid management.